| 发明名称 |
USE OF MUTANTS OF CC CHEMOKINES FOR TREATMENT OF MULTIPLE SCLEROSIS |
| 摘要 |
Mutants of CC chemokines, which contain at least two mutations in the cationic site of the 40's loop and which, relative to the wild-type molecule, have a reduced GAG-binding activity. In particular it has been found that such mutated chemokines are effective in the treatment of multiple sclerosis and/or other demyelinating diseases.
|
| 申请公布号 |
UA77950(C2) |
申请公布日期 |
2007.02.15 |
| 申请号 |
UA20030044038 |
申请日期 |
2001.10.03 |
| 申请人 |
APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. |
发明人 |
|
| 分类号 |
A61K38/19;C12N15/09;A61K38/00;A61P25/00;A61P25/28;C07K14/47;C07K14/52;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/19;C12P21/02;(IPC1-7):A61K/19;A61P/28;C07K/52;C12N/19 |
主分类号 |
A61K38/19 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
